Quarterly EPS earnings growth: Alcon Vision (ALC)

ALC (Alcon) - company brandmark

Alcon Inc. operates a resilient business that is independent of seasonality and macroeconomic shocks. This chart of quarterly EPS growth rates provided by GURU.Markets visualizes income dynamics, where -100.10 describes the current status of the metric. While risks are linked to regulatory pressure and competition, patents provide the company with strong pricing power and stable demand.

alcon.com (ALC) Year-over-year earnings per share growth for the last twelve months: for the period 07/04/2022 - 11/11/2026

Analytical breakdowns for Alcon Inc.

- market value and analyst target forecast:
Price Chart Alcon|ALC - Analyst Median Target
- company stock exchange capitalization indicators:
Market Capitalization Alcon Vision|ALC - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Alcon|ALC - Company Book Value|Market Capitalization to Book Value Ratio alcon.com|ALC - Cumulative Company Assets
- debt and liquidity data:
Debt to Equity Alcon Inc.|ALC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Alcon Inc.|ALC - Company Aggregate Debt|Debt to Book Value Alcon Vision|ALC - Company Long-Term Loans and Borrowings|Company Short-Term Debts Alcon|Quick Liquidity alcon.com
- earnings and market multiples details:
ALC - Company Profit|Projected Future Earnings Alcon Inc.|ALC - Price to Earnings Ratio|Projected Price to Earnings Alcon Vision|ALC - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Alcon Vision|ALC - Operating profit EBITDA|Earnings per share for the last twelve months Alcon|ALC - Earnings per share for the last twelve months|Quarterly EPS earnings growth alcon.com|ALC - Net earnings per share growth this year|Net earnings per share growth forecast for next year Alcon Inc.
Summary company analysis:Alcon, ALC
Manufactured product of Alcon Inc.

For Alcon Inc. (ALC), with its patent dominance in ophthalmic surgery, monitoring earnings per share confirms the resilience of the business model. This metric measures the percentage change in quarterly net income relative to the same period last year. By analyzing the quarterly shift in earnings per share, an investor assesses the efficiency of capitalizing on market barriers. Negative momentum signals a risk of reduced cash flow, while growth in this indicator confirms the company's ability to convert its technological advantage into actual revenue.

Who Alcon Inc. competes with

Bausch + Lomb (BLCO) - Year-over-year earnings per share growth for the last twelve months|GKOS - Year-over-year net earnings per share change for the last twelve months|APLS (Apellis Pharmaceuticals Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth belitebio.com|Year-over-year earnings per share growth for the last twelve months Ocular Therapeutix (OCUL)|Year-over-year earnings per share growth for the last twelve months HROW (harrowinc.com)|Quarterly EPS earnings growth VRDN (Viridian Therapeutics, Inc.)|LENZ - Year-over-year net earnings per share growth for the last 12 months|OCS - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months EyePoint Corp|Kodiak Sciences Inc. (KOD) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months ALDX|Year-over-year net earnings per share growth for the last 12 months KALA|IRD: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth OKYO|Year-over-year net earnings per share change for the last twelve months adverum.com|Year-over-year earnings per share growth for the last twelve months Outlook Therapeutics OTLK|CLSD: Year-over-year earnings per share growth for the last 12 months|NovaBay - Quarterly EPS earnings growth|Kiora Pharmaceuticals (KPRX) - Year-over-year net earnings per share growth for the last 12 months|ALIM (alimerasciences.com) - Year-over-year net earnings per share growth for the last 12 months|EYEN - Year-over-year net earnings per share change for the last twelve months|GHSI (Guardion Health Science) - Quarterly EPS earnings growth|Quarterly EPS earnings growth ocuphire.com|Year-over-year earnings per share growth for the last twelve months Opthea (OPT)